Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pdgfra-Associated Chronic Eosinophilic Leukemia × Immunoenzyme Techniques × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 4 Breast Neoplasms, Male 3 Breast Neoplasms 3 Sarcoma 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Kidney Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Leukemia 1 Hepatitis C 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma, Subependymal 1

Interventions

fludarabine phosphate 9 Whole-Body Irradiation 7 Peripheral Blood Stem Cell Transplantation 7 Cyclophosphamide 7 Busulfan 7 Mycophenolic Acid 6 Antilymphocyte Serum 6 Tacrolimus 5 Methotrexate 5 Cyclosporine 5 Melphalan 4 Etoposide 4 thymoglobulin 3 Sirolimus 3 Rituximab 3 Cord Blood Stem Cell Transplantation 3 Radiotherapy 2 Ondansetron 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cytarabine 2 Cyclosporins 2 Carmustine 2 Calcium Dobesilate 2 Aprepitant 2 rasburicase 1 fludarabine 1 etoposide phosphate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡